SCHEMBL17338641

SCHEMBL17338641

CC(C)C[C@H](NC(=O)c1c[nH]c2cc(Cc3ccccc3)c(Br)cc2c1=O)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ITGB2 P05107 3/20 0.44
ICAM1 P05362 3/20 0.44
ITGAL P20701 3/20 0.44
POLB P06746 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
GABRA1 P14867 2/20 0.43
GABRB2 P47870 2/20 0.43
GABRB1 P18505 1/20 0.43
GABRA3 P34903 1/20 0.43
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ECE1 P42892 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17338635 0.92 POLB (0.46) ITGB2ICAM1ITGALPOLBSMN1; SMN2
SCHEMBL17338614 0.92 POLB (0.46) ITGB2ICAM1ITGALPOLBSMN1; SMN2
SCHEMBL17338582 0.90 ITGB2 (0.51) ITGB2ICAM1ITGALPOLBKMT2A
SCHEMBL17338639 0.89 MAPT (0.47) POLBSMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL17338634 0.89 POLB (0.47) POLBSMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL17338648 0.87 POLB (0.46) ITGB2ICAM1ITGALPOLBSMN1; SMN2
SCHEMBL17338544 0.85 GABRA1 (0.60) POLBGABRA1GABRB2GABRB1GABRA3
SCHEMBL17338578 0.85 GABRA1 (0.60) POLBGABRA1GABRB2GABRB1GABRA3
SCHEMBL17338586 0.84 ALDH1A1 (0.54) ITGB2ICAM1ITGALPOLBSMN1; SMN2
SCHEMBL17338555 0.84 POLB (0.49) ITGB2ICAM1ITGALPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3145914-A1 AGENTS FOR USE IN THE TREATMENT OF CARDIOVASCULAR AND INFLAMMATORY DISEASES STRUCTURALLY BASED ON 4(1 H)-QUINOLONE UCL Business PLC (GB) 2017-03-29 EP disclosed
WO-2015189560-A1 AGENTS FOR USE IN THE TREATMENT OF CARDIOVASCULAR AND INFLAMMATORY DISEASES STRUCTURALLY BASED ON 4(1 H)-QUINOLONE UCL BUSINESS PLC (GB) 2015-12-17 WO disclosed